Nanotechnology in Medicine: From Molecules to Humans

医学纳米技术：从分子到人类

基本信息

批准号：
9195190
负责人：
Omolola Eniola-Adefeso
金额：
$ 1.3万
依托单位：
UNIVERSITY OF MICHIGAN AT ANN ARBOR
依托单位国家：
美国
项目类别：
财政年份：
2016
资助国家：
美国
起止时间：
2016-06-27 至 2017-05-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9195190
关键词：
Austria Baltimore Basic Science Binding Biological Products Biological Sciences Biomedical Engineering Biomedical Technology Caring Cell Adhesion Chemical Engineering Chemicals Clinical Engineering Collaborations County Denmark Detection Development Diagnostic Differentiation and Growth Disease Doctor of Philosophy Early Diagnosis Engineering Environmental Engineering technology Fostering Goals Health Health Status Human Image Institutes International Laboratories Location Medical Medicine Michigan Mission Names Nanotechnology National Institute of Biomedical Imaging and Bioengineering Ohio Polymers Portugal Research Research Personnel Science Scientist Technology Therapeutic Tissue Engineering United States National Institutes of Health Universities Viola drug development drug discovery human disease improved materials science mid-career faculty peer precision medicine professor programs response symposium technology development

项目摘要

The central objective of this ECI conference on Nanotechnology in Medicine is to provide a platform for global discussion amongst researchers in the field with the overall goal of aiding the mechanistic understanding of cellular and molecular interactions/responses induced by nanotechnologies and how we can better exploit these understandings to generate highly effective nanotechnologies for the early detection, imaging and treatment of human diseases. The conference will be held July 3 – 8, 2016 in Schloss Hernstein, Austria with Prof. Lola Eniola-Adefeso (University of Michigan) serving as conference chair and Dr. Paolo Decuzzi (Italian Institute of Technology) as co-chair. The conference will bring together biologists, materials scientists, physicists, engineers and clinical scientists from across the globe. This conference will represent a forum to discuss new opportunities and challenges in the field of nanotechnology in medicine and to foster the development of synergic collaborations among scientists with diverse backgrounds and expertise. As such, the Nanotechnology in Medicine ECI conference fit the mission of the National Institute of Biomedical Imaging and Bioengineering (NIBIB) “to improve health by leading the development and accelerating the application of biomedical technologies by the integration of the physical and engineering sciences with the life sciences to advance basic research and medical care.” The key topics to be covered in this conference include development of nanotechnology for (1) study of cell adhesion, growth and differentiation; and (2) for diagnostic, therapeutics and tissue engineering. Thus, we anticipate that the scientific interactions at this conference will foster “development of technologies for early disease detection and assessment of health status.

这次ECI纳米技术会议的核心目的是为该领域研究人员之间的全球讨论，其总体目标是协助机械了解纳米技术引起的细胞和分子相互作用/反应以及我们如何可以更好地利用这些理解来为早期产生高效的纳米技术人类疾病的检测，成像和治疗。会议将于2016年7月3日至8日在奥地利Schloss Hernstein，与Lola Eniola-adefeso教授（密歇根大学）一起担任会议主席和Paolo Decuzzi博士（意大利理工学院）担任联席主席。会议将聚集在一起来自全球的生物学家，材料科学家，物理学家，工程师和临床科学家。这会议将代表一个论坛，讨论该领域的新机遇和挑战医学领域的纳米技术，并促进科学家与潜水的背景和专业知识。因此，医学中的纳米技术会议适合美国国家生物医学成像与生物工程研究所（Nibib）的任务“以改善健康领导开发和加速生物医学技术的应用具有生命科学的物理和工程科学，以促进基础研究和医疗护理。” 本次会议中要涵盖的关键主题包括开发（1）细胞研究的纳米技术粘附，生长和分化；（2）用于诊断，治疗和组织工程。那，我们预计本次会议上的科学互动将促进“早期的技术开发疾病检测和健康状况评估。